NSCLC Isotoxic Hypofractionated Chemoradiotherapy

Clinical trial NCT03606239 · UNKNOWN

Trial details

NCT number: NCT03606239
Sponsor: The Second Hospital of Hebei Medical University
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2019-02-01
Primary completion: 2024-02-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.